Orthokeratology market size was valued at US$ 37.6 million in 2017, and is expected to witness a CAGR of 7.0% over the forecast period (2018 – 2026).

Orthokeratology (Ortho-K) is a non-surgical procedure using specially designed contact lenses to gently reshape the curvature of the eye to improve vision. It is most frequently used to temporarily correct myopia (near-sightedness). Ortho-k can correct upwards of -6.00 diopters (D) of myopia. It is also useful in correction of lesser degrees of astigmatism, presbyopia and hyperopia. Overnight ortho-K lenses are most commonly used in comparison to daytime wear. According to the Eye Contact Lens journal 2016 data, in the U.S., an estimated 500,000 to one million people were using ortho-K, whereas nearly 1.5 million ortho-K wearers were reported in China. Developments in peripheral refraction testing in combination with customized lens design is expected to show better myopia control with ortho-K.

Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2193

Market Dynamics

Increasing prevalence of myopia and high myopia around the world is the major factor driving the orthokeratology market growth. Myopia is the most common cause of correctable visual impairment among adults and children and is a leading cause of preventable blindness in emerging economies. According to a 2016, study published in National Center for Biotechnology Information (NCBI), myopia affects 1.89 billion people worldwide and it is projected to affect 2.56 billion people by 2020. Furthermore, myopia and high myopia will affect 52% (4,949 million) and 10.0% (925 million), respectively, of the world’s population by 2050.

Orthokeratology has become one of the most popular choices among children for refractive correction. However, with increasing adoption of Ortho-K worldwide, potential complications associated with the treatment have become a significant concern. Potential complications associated with Ortho-K include microbial keratitis, lens binding, and corneal staining. Microbial keratitis remains as the most serious and sight-threatening complication of Ortho-K. Moreover, increasing visibility of fibrillary lines, epithelial pigment deposit, and transient changes of corneal biomechanical properties are other clinically insignificant side effects of orthokeratology lens.

Flat USD 2000 OFF
Buy This Research Study Report @ https://www.coherentmarketinsights.com/promo/buynow/2193

Major Key Players Are: Autek China, Alpha Corporation, Bausch and Lomb Inc., Euclid Systems, E & E Optics, Essilor International S.A., GP Specialists, Paragon Vision Sciences, Procornea, and Taiwan Macro Vision Corporation.

Table of Content

Global Orthokeratology Market Research Report

Section 1: Global Orthokeratology Industry Overview
Section 2: Global Economic Impact on Orthokeratology Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Orthokeratology Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Orthokeratology Market Forecast

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.